Brief: Dr. Reddy's Canada Filed Application On Behalf Of Consortium For Reeqonus Tablets For Acute Treatment Of Mild-Moderate Covid-19 Adults
22/12/2020 06:43
Dec 22 (Reuters) - Dr. Reddy's:
* DR. REDDY’S - DR. REDDY’S CANADA FILED APPLICATION ON
BEHALF OF
CONSORTIUM FOR REEQONUS TABLETS FOR ACUTE TREATMENT OF
MILD-MODERATE COVID-19 ADULTS
Source text for Eikon: ID:nBw2XH0jwa
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez